Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-39,page-paged-39,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

CLIENT NEWS

 

 

  • Medigene AG: Medigene highlights its ‘iM (inducible Medigene)-TCR’ approach at CAR-TCR Summit 2019 in Boston, USA
    www.medigene.com
  • Rentschler Biopharma to highlight new U.S. facility and bioprocessing expertise at Biotech Week Boston
    www.rentschler-fill-solutions.com
  • Atriva Therapeutics takes part in four conferences in the upcoming months
    www.atriva-therapeutics.com
  • Vivoryon Therapeutics AG to Publish its Half Year 2019 Results on August 29, 2019
    www.vivoryon.com
  • Adrenomed Supervisory Board appoints Jens Schneider-Mergener as CEO and Jens Zimmermann, CMO, joins the Executive Board
    www.andrenomed.com
  • MagForce AG: MagForce USA, Inc. Completed Enrollment and Treatment for Stage 1 and Prepares for Next Stage of its Pivotal, Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with NanoTherm Therapy
    www.magforce.de
  • Rentschler Fill Solutions receives open-ended GMP certification by the Austrian authority AGES
    www.rentschler-fill-solutions.com
  • Adocia announces that the American Arbitration Association Tribunal dismissed all claims in second phase of arbitration with Eli Lilly
    www.adocia.com
  • Vivoryon Therapeutics AG to Publish its Half Year 2019 Results on August 29, 2019
    www.vivoryon.com
  • Ergomed plc: Ian Johnson Appointed as Non-Executive Director
    www.ergomedplc.com